Es wurden 8 Aussendungen gefunden
  • Eli Lilly and Company
Lilly veröffentlicht Aktualisierung über Tätigkeiten im Corporate-Responsibility-Bereich

(PRN) - - Unternehmen meldet Fortschritte bei zahlreichen ökonomischen, ökologischen und sozialen Leistungskennzahlen

  • 03.12.2012, 13:03:36
  • /
  • OTS0167 OTW0167
  • Eli Lilly and Company
Lilly Global gibt Mitarbeitern mehr Möglichkeiten zu gemeinnütziger Arbeit

Indianapolis (ots/PRNewswire) -

  • 26.07.2011, 01:59:03
  • /
  • OTS0002 OTW0002
  • Eli Lilly and Company
Lilly CEO Says Industry, Public Policy Must Pave Way For Innovation

London (ots/PRNewswire) - A new approach to research, along with public policies that support medical innovation, will help biopharmaceutical companies address stubborn diseases with potentially devastating personal...

  • 10.02.2011, 10:17:33
  • /
  • OTE0005
  • Eli Lilly and Company
Lilly Halts Development of Semagacestat for Alzheimer's Disease Based on Preliminary Results of Phase III Clinical Trials

Indianapolis, August 17, 2010 (ots/PRNewswire) - Eli Lilly and Company will halt development of semagacestat, a gamma secretase inhibitor being studied as a potential treatment for Alzheimer's disease, because preliminary...

  • 17.08.2010, 14:01:36
  • /
  • OTE0006
  • Eli Lilly and Company
Dr. Steven M. Paul to Retire from Lilly as Executive Vice President, Science and Technology, President, Lilly Research Laboratories; Dr. Jan M. Lundberg, Executive Vice President, Head of Global Discovery Research, AstraZeneca, Named his Successor

Indianapolis, November 13 (ots/PRNewswire) -

  • 13.11.2009, 15:11:41
  • /
  • OTE0006
  • Eli Lilly and Company
'Hair Again' gibt der 'Krebsreise' ihre Bedeutung

London, November 3 (ots/PRNewswire) -

  • 03.11.2006, 11:35:43
  • /
  • OTS0095 OTW0095
  • Eli Lilly and Company
Internationaler Lilly-Kunstwettbewerb und Ausstellung 2006 "Oncology on Canvas (SM)" verzeichnet über 2.000 Einsendungen

Indianapolis (ots/PRNewswire) -

  • 28.09.2006, 18:03:08
  • /
  • OTS0308 OTW0308
  • Eli Lilly and Company
Eli Lilly and Company and Boehringer Ingelheim Announce Changes to Their Contractual Agreements for Yentreve(R)/AriClaim(R)

Indianapolis, and Ingelheim, Germany (ots/PRNewswire) -

  • 15.02.2006, 12:10:39
  • /
  • OTE0003